InvestorsHub Logo

rayovacAAA

12/06/22 8:19 AM

#389700 RE: blue finch #389698

EXPECT AVXL TO ANNOUNCE BILLIONS IN REVENUE FROM A2-73 AD SAS APPROVAL SALES WITHIN THE NEXT 2 WEEKS!!!!!!!!!!!!!!!!!!!!!!!

If Alzheimer's draws revenues from Australia or Japan in next two years
He will be proven wrong

Bullish
Bullish

Zadie420

12/06/22 8:28 AM

#389706 RE: blue finch #389698

Agreed with you to go after AU/Japan first and a few other Industriazed countries. They have a better chance to generate a lot of revenue quickly. While they are at it they can collect and monitor some patients for future data before they approach FDA . If data is solid which I expect that I do not see any objection from FDA to approve our drug.